Free Trial
NASDAQ:LFVN

LifeVantage (LFVN) Stock Price, News & Analysis

LifeVantage logo
$12.87 +0.22 (+1.74%)
As of 06/12/2025 04:00 PM Eastern

About LifeVantage Stock (NASDAQ:LFVN)

Key Stats

Today's Range
$12.52
$12.87
50-Day Range
$11.18
$15.30
52-Week Range
$5.22
$27.38
Volume
65,622 shs
Average Volume
145,371 shs
Market Capitalization
$162.01 million
P/E Ratio
22.98
Dividend Yield
1.40%
Price Target
$30.50
Consensus Rating
Buy

Company Overview

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, it offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website and network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company was founded in 2003 and is headquartered in Lehi, Utah.

LifeVantage Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
81st Percentile Overall Score

LFVN MarketRank™: 

LifeVantage scored higher than 81% of companies evaluated by MarketBeat, and ranked 191st out of 942 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    LifeVantage has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    LifeVantage has received no research coverage in the past 90 days.

  • Read more about LifeVantage's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of LifeVantage is 22.98, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.31.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of LifeVantage is 22.98, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.14.

  • Price to Book Value per Share Ratio

    LifeVantage has a P/B Ratio of 5.41. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about LifeVantage's valuation and earnings.
  • Percentage of Shares Shorted

    19.68% of the float of LifeVantage has been sold short.
  • Short Interest Ratio / Days to Cover

    LifeVantage has a short interest ratio ("days to cover") of 11.1, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in LifeVantage has recently increased by 11.80%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    LifeVantage pays a meaningful dividend of 1.44%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    LifeVantage has only been increasing its dividend for 3 years.

  • Dividend Coverage

    The dividend payout ratio of LifeVantage is 26.09%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about LifeVantage's dividend.
  • Percentage of Shares Shorted

    19.68% of the float of LifeVantage has been sold short.
  • Short Interest Ratio / Days to Cover

    LifeVantage has a short interest ratio ("days to cover") of 11.1, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in LifeVantage has recently increased by 11.80%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    LifeVantage has a news sentiment score of 1.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for LifeVantage this week, compared to 3 articles on an average week.
  • Search Interest

    1 people have searched for LFVN on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, LifeVantage insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    20.65% of the stock of LifeVantage is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 35.32% of the stock of LifeVantage is held by institutions.

  • Read more about LifeVantage's insider trading history.
Receive LFVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeVantage and its competitors with MarketBeat's FREE daily newsletter.

LFVN Stock News Headlines

Why July 22nd Could Mean Big Changes for Social Security
In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Social Security — and his plan is set to roll out July 22. What's coming next isn't about trimming waste.
See More Headlines

LFVN Stock Analysis - Frequently Asked Questions

LifeVantage's stock was trading at $17.53 on January 1st, 2025. Since then, LFVN stock has decreased by 26.6% and is now trading at $12.87.
View the best growth stocks for 2025 here
.

LifeVantage Co. (NASDAQ:LFVN) announced its earnings results on Tuesday, May, 6th. The company reported $0.26 EPS for the quarter, beating analysts' consensus estimates of $0.16 by $0.10. The company had revenue of $58.44 million for the quarter, compared to the consensus estimate of $60.99 million. LifeVantage had a trailing twelve-month return on equity of 34.29% and a net margin of 3.46%.
Read the conference call transcript
.

Top institutional investors of LifeVantage include Capital Management Corp VA (5.70%), Driehaus Capital Management LLC (3.65%), Acadian Asset Management LLC (2.32%) and Envestnet Asset Management Inc. (1.10%). Insiders that own company stock include Judd Dayton, Darwin Lewis, Raymond B Greer, Garry Paul Mauro and Michael A Beindorff.
View institutional ownership trends
.

Shares of LFVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that LifeVantage investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and iShares Micro-Cap ETF (IWC).

Company Calendar

Record date for 3/17 Dividend
3/03/2025
Ex-Dividend for 3/17 Dividend
3/03/2025
Dividend Payable
3/17/2025
Last Earnings
5/06/2025
Record date for 6/13 Dividend
5/30/2025
Ex-Dividend for 6/13 Dividend
5/30/2025
Today
6/13/2025
Dividend Payable
6/13/2025
Fiscal Year End
6/30/2025
Next Earnings (Estimated)
8/27/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:LFVN
Employees
260
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$30.50
High Stock Price Target
$35.00
Low Stock Price Target
$26.00
Potential Upside/Downside
+137.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
22.98
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$2.94 million
Pretax Margin
4.86%

Debt

Sales & Book Value

Annual Sales
$222.35 million
Cash Flow
$0.68 per share
Price / Cash Flow
19.03
Book Value
$2.38 per share
Price / Book
5.41

Miscellaneous

Free Float
9,959,000
Market Cap
$162.01 million
Optionable
Optionable
Beta
0.43

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:LFVN) was last updated on 6/13/2025 by MarketBeat.com Staff
From Our Partners